Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Neuroimage. Clinical
|
January 5, 2021
Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum
Meret Herdick, Martin Dyrba, Hans-Christian J Fritz, et al.
Brain : a Journal of Neurology
|
March 30, 2022
Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction
Emrah Düzel, Gabriel Ziegler, David Berron, et al.
Neurology
|
September 20, 2024
Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline
Xiao Wang, Silka D Freiesleben, Luisa-Sophie Schneider, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
June 3, 2021
Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes
Boris-Stephan Rauchmann, Ersin Ersoezlue, Sophia Stoecklein, et al.
The Journal of Prevention of Alzheimer'S Disease
|
March 29, 2026
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease
Arda C Cetindag, Carola G Schipke, Hermann Esselmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 3, 2025
Replication of blood DNA methylomic signatures associated with cerebrospinal fluid levels of YKL-40 and NfL biomarkers
Timo Kaleck, Rafael Campos-Martin, Amanda Cano, et al.
Journal of Alzheimer'S Disease Reports
|
October 18, 2023
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach
Stefan J Teipel, Martin Dyrba, Fedor Levin, et al.
Alzheimer'S Research & Therapy
|
November 24, 2021
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease
Martin Dyrba, Moritz Hanzig, Slawek Altenstein, et al.
Brain Communications
|
February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum
Lena Haag, Elisa Lancini, Renat Yakupov, et al.
Brain : a Journal of Neurology
|
October 26, 2022
Cholinergic white matter pathways along the Alzheimer's disease continuum
Milan Nemy, Martin Dyrba, Frederic Brosseron, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Neuroimage. Clinical
|
January 5, 2021
Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum
Meret Herdick, Martin Dyrba, Hans-Christian J Fritz, et al.
Brain : a Journal of Neurology
|
March 30, 2022
Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction
Emrah Düzel, Gabriel Ziegler, David Berron, et al.
Neurology
|
September 20, 2024
Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline
Xiao Wang, Silka D Freiesleben, Luisa-Sophie Schneider, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
June 3, 2021
Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes
Boris-Stephan Rauchmann, Ersin Ersoezlue, Sophia Stoecklein, et al.
The Journal of Prevention of Alzheimer'S Disease
|
March 29, 2026
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease
Arda C Cetindag, Carola G Schipke, Hermann Esselmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 3, 2025
Replication of blood DNA methylomic signatures associated with cerebrospinal fluid levels of YKL-40 and NfL biomarkers
Timo Kaleck, Rafael Campos-Martin, Amanda Cano, et al.
Journal of Alzheimer'S Disease Reports
|
October 18, 2023
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach
Stefan J Teipel, Martin Dyrba, Fedor Levin, et al.
Alzheimer'S Research & Therapy
|
November 24, 2021
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease
Martin Dyrba, Moritz Hanzig, Slawek Altenstein, et al.
Brain Communications
|
February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum
Lena Haag, Elisa Lancini, Renat Yakupov, et al.
Brain : a Journal of Neurology
|
October 26, 2022
Cholinergic white matter pathways along the Alzheimer's disease continuum
Milan Nemy, Martin Dyrba, Frederic Brosseron, et al.
Page
of 11